Global Neurovascular Devices Market Growth (Status and Outlook) 2026-2032
The global Neurovascular Devices market size is predicted to grow from US$ 6690 million in 2025 to US$ 12516 million in 2032; it is expected to grow at a CAGR of 9.0% from 2026 to 2032.
Neurovascular Devices are high-value medical devices used in minimally invasive endovascular diagnosis and treatment of cerebrovascular diseases through catheter-based access to the intracranial and cervical vasculature. The market centers on devices that establish vascular access, remove thrombus, reconstruct blood flow, embolize pathological vessels or aneurysms, and deliver therapeutic implants. Core product forms include aspiration and access catheters, balloon guide catheters, microcatheters, microwires, stent retrievers, intracranial stents, flow diverters, intrasaccular mesh devices, detachable coils, liquid embolic agents, and related aspiration or detachment control equipment. These devices are primarily used in Acute Ischemic Stroke, Intracranial Aneurysm, intracranial atherosclerotic disease, arteriovenous malformations, dural arteriovenous fistulas, and other complex neurovascular conditions. The market is characterized by high technical barriers, stringent clinical and regulatory requirements, strong physician dependence, and substantial interoperability between access, delivery, treatment, and support devices.
Stent and Mesh Devices represented 36.18% of 2025 revenue, the largest product category
Intracranial Aneurysm applications accounted for 61.88% of 2025 revenue, while Acute Ischemic Stroke reached 24.08%
The six first-tier manufacturers together represented approximately 68.60% of 2025 global revenue
Application structure is also changing. Intracranial Aneurysm remained the largest application in 2025 with 61.88% of revenue, but Acute Ischemic Stroke reached 24.08% and is expanding more rapidly as thrombectomy adoption broadens. By 2032, the respective shares are expected to move toward approximately 49.90% and 30.12%, indicating a gradual rebalancing from an aneurysm-dominated market toward a more diversified combination of aneurysm treatment, stroke intervention, and other neurovascular procedures. Radial Artery Access shows a similar structural shift, increasing from 17.53% of 2025 revenue toward 27.07% by 2032, although Femoral Artery Access remains the principal procedural route.
This Insight Report provides a comprehensive analysis of the global Neurovascular Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurovascular Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Devices market by product type, application, key players and key regions and countries.
Neurovascular Devices are high-value medical devices used in minimally invasive endovascular diagnosis and treatment of cerebrovascular diseases through catheter-based access to the intracranial and cervical vasculature. The market centers on devices that establish vascular access, remove thrombus, reconstruct blood flow, embolize pathological vessels or aneurysms, and deliver therapeutic implants. Core product forms include aspiration and access catheters, balloon guide catheters, microcatheters, microwires, stent retrievers, intracranial stents, flow diverters, intrasaccular mesh devices, detachable coils, liquid embolic agents, and related aspiration or detachment control equipment. These devices are primarily used in Acute Ischemic Stroke, Intracranial Aneurysm, intracranial atherosclerotic disease, arteriovenous malformations, dural arteriovenous fistulas, and other complex neurovascular conditions. The market is characterized by high technical barriers, stringent clinical and regulatory requirements, strong physician dependence, and substantial interoperability between access, delivery, treatment, and support devices.
Key Findings
North America accounted for 36.10% of 2025 global revenue, remaining the largest regional marketStent and Mesh Devices represented 36.18% of 2025 revenue, the largest product category
Intracranial Aneurysm applications accounted for 61.88% of 2025 revenue, while Acute Ischemic Stroke reached 24.08%
The six first-tier manufacturers together represented approximately 68.60% of 2025 global revenue
Market Trends
The Neurovascular Devices market is moving from single-device innovation toward integrated treatment platforms combining vascular access, aspiration, thrombectomy, embolization, and flow reconstruction. In stroke intervention, product development is increasingly focused on larger effective aspiration lumens, lower-profile shafts, improved distal navigability, stronger proximal support, and compatibility between aspiration catheters and stent retrievers. Treatment is also extending from conventional large-vessel occlusion toward selected medium and distal vessel occlusions, raising requirements for smaller-profile and more atraumatic systems. In aneurysm treatment, flow diversion and intrasaccular flow disruption are expanding the range of complex lesions that can be treated endovascularly, while coils remain clinically important but face greater differentiation pressure. Radial access is developing into a distinct device design pathway, supporting longer working lengths and lower-profile access platforms. Across the market, competitive advantage is increasingly determined by the performance of the complete procedural system rather than an isolated implant, making clinical evidence, device compatibility, physician usability, and continuous portfolio renewal more important.Market Dynamics
Drivers
Demand is supported by the persistent global burden of stroke and cerebrovascular disease, population aging, broader availability of neuroimaging, expansion of organized stroke care, and greater adoption of endovascular treatment. Mechanical thrombectomy has become a core treatment pathway for eligible Acute Ischemic Stroke patients, increasing demand not only for thrombectomy devices but also for aspiration, access, microcatheter, guidewire, and support systems used in the same procedure. Growth in specialized neurointerventional centers and improved referral networks are increasing the number of patients who can reach definitive treatment within clinically relevant time windows. At the same time, new device architectures for flow diversion, intrasaccular treatment, aspiration, and intracranial delivery continue to improve the treatability of anatomically complex lesions, supporting higher procedural penetration and a broader addressable patient population.Restraints
Neurovascular intervention remains highly dependent on specialized physicians, advanced imaging infrastructure, catheterization laboratories, and coordinated emergency pathways, resulting in substantial differences in treatment accessibility between countries and hospitals. Product development also requires sophisticated engineering, biocompatible materials, manufacturing consistency, clinical evidence, and extensive regulatory documentation, creating long commercialization cycles and high development costs. Reimbursement and hospital budgeting can delay adoption even after regulatory approval, particularly for premium-priced devices whose incremental clinical value must be demonstrated against established alternatives. In several markets, centralized procurement, tendering, and price linkage are increasing pressure on mature coils, intracranial stents, and other standardized products, limiting pricing flexibility and shifting profitability toward differentiated devices and broader treatment platforms.Opportunities
The most attractive opportunities are concentrated in clinical areas where treatment penetration remains below technical feasibility. Medium and distal vessel thrombectomy, advanced aspiration systems, low-profile flow diversion, intrasaccular aneurysm treatment, transradial neurointervention, intracranial atherosclerotic disease, and embolization of additional neurovascular targets offer room for portfolio expansion. China, Southeast Asia, and other markets with improving stroke networks provide additional opportunities as neurointerventional capability expands beyond major tertiary centers. Another important opportunity lies in platform integration: manufacturers that combine access, delivery, treatment, and supporting devices can capture a larger share of procedural value while improving workflow compatibility. International expansion by emerging manufacturers also creates opportunities for licensing, distribution partnerships, technology collaboration, and strategic acquisitions as locally developed platforms seek broader regulatory approval.Challenges
The market faces rapid technology cycles and a high risk of product substitution. A successful new aspiration catheter, thrombectomy system, flow diverter, or access platform can quickly alter purchasing patterns, while innovation may also cannibalize a manufacturer's own mature portfolio. Clinical adoption requires physician training and evidence generation, particularly for devices introducing new treatment mechanisms or targeting smaller and more distal vessels. Manufacturers must simultaneously maintain quality systems, post-market surveillance, traceability, supply continuity, and regulatory compliance across multiple jurisdictions. Intensifying competition from global platform companies, specialized innovators, and increasingly capable Chinese manufacturers raises the threshold for sustained differentiation. Exchange-rate movements, localization policies, procurement reforms, and cross-border regulatory requirements can further affect realized pricing and profitability.Industry Chain Analysis
The upstream chain comprises medical-grade metals and polymers, including nitinol, platinum-group and radiopaque materials, stainless steel, fluoropolymers, engineered thermoplastics, hydrophilic coating materials, adhesives, and precision tubing or wire components. These inputs are transformed through highly controlled processes such as catheter extrusion and reinforcement, braiding, laser cutting, heat setting, coil winding, surface treatment, coating, micro-assembly, inspection, packaging, and sterilization. Midstream manufacturers create most of the economic value through device architecture, material engineering, process control, clinical validation, intellectual property, regulatory approval, and portfolio integration rather than through raw-material cost alone. Downstream demand is generated primarily by hospitals, comprehensive stroke centers, neurointerventional departments, and specialized cerebrovascular centers, with distribution structures varying by geography. Value capture increasingly depends on the ability to support an entire procedure, because thrombectomy and aneurysm treatment commonly require several compatible devices in a single case. This favors suppliers capable of combining high-value therapeutic implants with recurring access and delivery consumables while maintaining clinical support, physician training, and reliable supply.Segment Insights
Stent and Mesh Devices represented 36.18% of the market in 2025 and are projected to account for approximately 37.33% by 2032, supported by thrombectomy, flow diversion, intracranial support, and intrasaccular treatment. Catheter Devices are gaining structural importance, with their share increasing from 25.91% in 2025 toward 29.41% by 2032 as large-bore aspiration and distal access become more central to complex procedures. Coil Devices remain an established treatment category, but their share is expected to decline from 27.60% to about 22.40% as alternative aneurysm treatment technologies gain adoption. By implantation status, Temporary Intravascular Devices represented 52.75% in 2025 and are expected to become increasingly important because modern thrombectomy and complex intervention require multiple access, aspiration, support, and retrieval components.Application structure is also changing. Intracranial Aneurysm remained the largest application in 2025 with 61.88% of revenue, but Acute Ischemic Stroke reached 24.08% and is expanding more rapidly as thrombectomy adoption broadens. By 2032, the respective shares are expected to move toward approximately 49.90% and 30.12%, indicating a gradual rebalancing from an aneurysm-dominated market toward a more diversified combination of aneurysm treatment, stroke intervention, and other neurovascular procedures. Radial Artery Access shows a similar structural shift, increasing from 17.53% of 2025 revenue toward 27.07% by 2032, although Femoral Artery Access remains the principal procedural route.
Downstream Market Opportunities
Downstream opportunities are increasingly determined by procedural capability rather than disease prevalence alone. Comprehensive stroke centers and hospitals capable of providing 24-hour imaging, angiography, mechanical thrombectomy, aneurysm embolization, and neurocritical care generate the highest-value demand because they use multiple devices during each intervention and are more likely to adopt advanced platforms. Expansion of stroke networks can extend thrombectomy and neurovascular treatment to a wider geographic patient base, while complex aneurysms create demand for flow diversion, intrasaccular systems, coils, and sophisticated delivery platforms. Additional opportunities are emerging in intracranial stenosis, vascular malformations, dural arteriovenous fistulas, and middle meningeal artery embolization, where improved embolic agents, microcatheters, balloon technologies, and intracranial access systems can broaden treatment options.Regional Insights
North America remained the largest regional market in 2025 with a 36.10% share, supported by mature neurointerventional infrastructure, high adoption of mechanical thrombectomy and advanced aneurysm therapies, and strong commercialization of new technologies. Europe accounted for 23.44%, with demand shaped by broad clinical adoption but differentiated reimbursement and procurement conditions across national markets. China represented 22.06% and is expected to increase its global share to approximately 23.85% by 2032 as stroke-center capability, domestic device availability, and neurointerventional treatment penetration expand. Japan retains a technically mature and highly regulated market, while Southeast Asia remains smaller in absolute share but is among the fastest-expanding major regions, with an estimated 2026-2032 CAGR of approximately 12.90%. The regional opportunity is therefore shifting gradually toward Asian markets where procedural capacity and treatment penetration are still increasing, while mature markets remain critical for premium technologies and clinical validation.Competitive Landscape Analysis
Competition is characterized by a combination of large global platform companies and specialized innovation-driven manufacturers. Medtronic, Stryker, Terumo, Penumbra, Johnson & Johnson, and BALT constituted the first tier in 2025 and together represented approximately 68.60% of global revenue, reflecting advantages in portfolio breadth, clinical evidence, regulatory capabilities, physician relationships, and international commercial infrastructure. A second group including Wallaby Medical, MicroPort Neuro, Zylox-Tonbridge, Acandis, Peijia Medical, and ASAHI INTECC has established meaningful positions in selected technologies or regional markets, collectively accounting for approximately 8.84%. Competitive differentiation is increasingly shifting from individual product performance toward platform completeness. Large companies are strengthening integrated stroke and aneurysm portfolios, while specialized companies compete through distinct technologies in aspiration, flow diversion, thrombectomy, intracranial support, and access. Chinese manufacturers are moving beyond basic import substitution toward higher-value devices and international registration, increasing competitive pressure in China and progressively in overseas markets. As product performance converges, long-term advantage is likely to depend more heavily on clinical evidence, continuous innovation, manufacturing quality, portfolio interoperability, and the ability to commercialize across multiple regulatory and reimbursement environments.Report Scope
LPI (LP Information)' newest research report, the “Neurovascular Devices Industry Forecast” looks at past sales and reviews total world Neurovascular Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurovascular Devices sales for 2026 through 2032. With Neurovascular Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Devices industry.This Insight Report provides a comprehensive analysis of the global Neurovascular Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Neurovascular Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Devices market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Catheter-Based Devices
- Stent and Mesh-Based Devices
- Coil-Based Devices
- Others
Segmentation by Implantation Status:
- Permanent Implantable and Embolic Products
- Temporary Intravascular Devices
- External Equipment
Segmentation by Access Route:
- Femoral Artery Access
- Radial Artery Access
- Others
Segmentation by Application:
- Acute Ischemic Stroke
- Intracranial Aneurysm
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic plc
- Stryker Corporation
- Terumo Corporation
- Penumbra, Inc.
- Johnson & Johnson
- BALT SAS
- Wallaby Medical Holding, Inc.
- MicroPort NeuroScientific Corporation
- Zylox-Tonbridge Medical Technology Co., Ltd.
- ACANDIS GmbH
- Peijia Medical Limited
- ASAHI INTECC CO., LTD.
- Imperative Care, Inc.
- Shanghai HeartCare Medical Technology Corporation Limited
- Sino Medical Sciences Technology Inc.
- Beijing Taijie Weiye Technology Co., Ltd.
- Skynor Medical (Shanghai) Co., Ltd.
- Rapid Medical Ltd.
- Hunan Ruikangtong Technology Development Co., Ltd.
- Suzhou Zenith Vascular Co., Ltd.
- KANEKA CORPORATION
- Route 92 Medical, Inc.
- Q'Apel Medical, Inc.
- Vesalio, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Devices Market Size (2021-2032)
2.1.2 Neurovascular Devices Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neurovascular Devices by Country/Region (2021, 2025 & 2032)
2.2 Neurovascular Devices Segment by Type
2.2.1 Catheter-Based Devices
2.2.2 Stent and Mesh-Based Devices
2.2.3 Coil-Based Devices
2.2.4 Others
2.2.5 Neurovascular Devices Market Size by Type
2.2.5.1 Neurovascular Devices Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Neurovascular Devices Market Size Market Share by Type (2021-2026)
2.3 Neurovascular Devices Segment by Implantation Status
2.3.1 Permanent Implantable and Embolic Products
2.3.2 Temporary Intravascular Devices
2.3.3 External Equipment
2.3.4 Neurovascular Devices Market Size by Implantation Status
2.3.4.1 Neurovascular Devices Market Size CAGR by Implantation Status (2021 VS 2025 VS 2032)
2.3.4.2 Global Neurovascular Devices Market Size Market Share by Implantation Status (2021-2026)
2.4 Neurovascular Devices Segment by Access Route
2.4.1 Femoral Artery Access
2.4.2 Radial Artery Access
2.4.3 Others
2.4.4 Neurovascular Devices Market Size by Access Route
2.4.4.1 Neurovascular Devices Market Size CAGR by Access Route (2021 VS 2025 VS 2032)
2.4.4.2 Global Neurovascular Devices Market Size Market Share by Access Route (2021-2026)
2.5 Neurovascular Devices Segment by Application
2.5.1 Acute Ischemic Stroke
2.5.2 Intracranial Aneurysm
2.5.3 Others
2.5.4 Neurovascular Devices Market Size by Application
2.5.4.1 Neurovascular Devices Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Neurovascular Devices Market Size Market Share by Application (2021-2026)
3 NEUROVASCULAR DEVICES MARKET SIZE BY PLAYER
3.1 Neurovascular Devices Market Size Market Share by Player
3.1.1 Global Neurovascular Devices Revenue by Player (2021-2026)
3.1.2 Global Neurovascular Devices Revenue Market Share by Player (2021-2026)
3.2 Global Neurovascular Devices Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROVASCULAR DEVICES BY REGION
4.1 Neurovascular Devices Market Size by Region (2021-2026)
4.2 Global Neurovascular Devices Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurovascular Devices Market Size Growth (2021-2026)
4.4 APAC Neurovascular Devices Market Size Growth (2021-2026)
4.5 Europe Neurovascular Devices Market Size Growth (2021-2026)
4.6 Middle East & Africa Neurovascular Devices Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neurovascular Devices Market Size by Country (2021-2026)
5.2 Americas Neurovascular Devices Market Size by Type (2021-2026)
5.3 Americas Neurovascular Devices Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Devices Market Size by Region (2021-2026)
6.2 APAC Neurovascular Devices Market Size by Type (2021-2026)
6.3 APAC Neurovascular Devices Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurovascular Devices Market Size by Country (2021-2026)
7.2 Europe Neurovascular Devices Market Size by Type (2021-2026)
7.3 Europe Neurovascular Devices Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Devices by Region (2021-2026)
8.2 Middle East & Africa Neurovascular Devices Market Size by Type (2021-2026)
8.3 Middle East & Africa Neurovascular Devices Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST
10.1 Global Neurovascular Devices Forecast by Region (2027-2032)
10.1.1 Global Neurovascular Devices Forecast by Region (2027-2032)
10.1.2 Americas Neurovascular Devices Forecast
10.1.3 APAC Neurovascular Devices Forecast
10.1.4 Europe Neurovascular Devices Forecast
10.1.5 Middle East & Africa Neurovascular Devices Forecast
10.2 Americas Neurovascular Devices Forecast by Country (2027-2032)
10.2.1 United States Market Neurovascular Devices Forecast
10.2.2 Canada Market Neurovascular Devices Forecast
10.2.3 Mexico Market Neurovascular Devices Forecast
10.2.4 Brazil Market Neurovascular Devices Forecast
10.3 APAC Neurovascular Devices Forecast by Region (2027-2032)
10.3.1 China Neurovascular Devices Market Forecast
10.3.2 Japan Market Neurovascular Devices Forecast
10.3.3 Korea Market Neurovascular Devices Forecast
10.3.4 Southeast Asia Market Neurovascular Devices Forecast
10.3.5 India Market Neurovascular Devices Forecast
10.3.6 Australia Market Neurovascular Devices Forecast
10.4 Europe Neurovascular Devices Forecast by Country (2027-2032)
10.4.1 Germany Market Neurovascular Devices Forecast
10.4.2 France Market Neurovascular Devices Forecast
10.4.3 UK Market Neurovascular Devices Forecast
10.4.4 Italy Market Neurovascular Devices Forecast
10.4.5 Russia Market Neurovascular Devices Forecast
10.5 Middle East & Africa Neurovascular Devices Forecast by Region (2027-2032)
10.5.1 Egypt Market Neurovascular Devices Forecast
10.5.2 South Africa Market Neurovascular Devices Forecast
10.5.3 Israel Market Neurovascular Devices Forecast
10.5.4 Turkey Market Neurovascular Devices Forecast
10.6 Global Neurovascular Devices Forecast by Type (2027-2032)
10.7 Global Neurovascular Devices Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neurovascular Devices Forecast
11 KEY PLAYERS ANALYSIS
11.1 Medtronic plc
11.1.1 Medtronic plc Company Information
11.1.2 Medtronic plc Neurovascular Devices Product Offered
11.1.3 Medtronic plc Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Medtronic plc Main Business Overview
11.1.5 Medtronic plc Latest Developments
11.2 Stryker Corporation
11.2.1 Stryker Corporation Company Information
11.2.2 Stryker Corporation Neurovascular Devices Product Offered
11.2.3 Stryker Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Stryker Corporation Main Business Overview
11.2.5 Stryker Corporation Latest Developments
11.3 Terumo Corporation
11.3.1 Terumo Corporation Company Information
11.3.2 Terumo Corporation Neurovascular Devices Product Offered
11.3.3 Terumo Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Terumo Corporation Main Business Overview
11.3.5 Terumo Corporation Latest Developments
11.4 Penumbra, Inc.
11.4.1 Penumbra, Inc. Company Information
11.4.2 Penumbra, Inc. Neurovascular Devices Product Offered
11.4.3 Penumbra, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Penumbra, Inc. Main Business Overview
11.4.5 Penumbra, Inc. Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Neurovascular Devices Product Offered
11.5.3 Johnson & Johnson Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 BALT SAS
11.6.1 BALT SAS Company Information
11.6.2 BALT SAS Neurovascular Devices Product Offered
11.6.3 BALT SAS Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 BALT SAS Main Business Overview
11.6.5 BALT SAS Latest Developments
11.7 Wallaby Medical Holding, Inc.
11.7.1 Wallaby Medical Holding, Inc. Company Information
11.7.2 Wallaby Medical Holding, Inc. Neurovascular Devices Product Offered
11.7.3 Wallaby Medical Holding, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Wallaby Medical Holding, Inc. Main Business Overview
11.7.5 Wallaby Medical Holding, Inc. Latest Developments
11.8 MicroPort NeuroScientific Corporation
11.8.1 MicroPort NeuroScientific Corporation Company Information
11.8.2 MicroPort NeuroScientific Corporation Neurovascular Devices Product Offered
11.8.3 MicroPort NeuroScientific Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 MicroPort NeuroScientific Corporation Main Business Overview
11.8.5 MicroPort NeuroScientific Corporation Latest Developments
11.9 Zylox-Tonbridge Medical Technology Co., Ltd.
11.9.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
11.9.2 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Product Offered
11.9.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
11.9.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
11.10 ACANDIS GmbH
11.10.1 ACANDIS GmbH Company Information
11.10.2 ACANDIS GmbH Neurovascular Devices Product Offered
11.10.3 ACANDIS GmbH Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 ACANDIS GmbH Main Business Overview
11.10.5 ACANDIS GmbH Latest Developments
11.11 Peijia Medical Limited
11.11.1 Peijia Medical Limited Company Information
11.11.2 Peijia Medical Limited Neurovascular Devices Product Offered
11.11.3 Peijia Medical Limited Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Peijia Medical Limited Main Business Overview
11.11.5 Peijia Medical Limited Latest Developments
11.12 ASAHI INTECC CO., LTD.
11.12.1 ASAHI INTECC CO., LTD. Company Information
11.12.2 ASAHI INTECC CO., LTD. Neurovascular Devices Product Offered
11.12.3 ASAHI INTECC CO., LTD. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ASAHI INTECC CO., LTD. Main Business Overview
11.12.5 ASAHI INTECC CO., LTD. Latest Developments
11.13 Imperative Care, Inc.
11.13.1 Imperative Care, Inc. Company Information
11.13.2 Imperative Care, Inc. Neurovascular Devices Product Offered
11.13.3 Imperative Care, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Imperative Care, Inc. Main Business Overview
11.13.5 Imperative Care, Inc. Latest Developments
11.14 Shanghai HeartCare Medical Technology Corporation Limited
11.14.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
11.14.2 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Product Offered
11.14.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
11.14.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
11.15 Sino Medical Sciences Technology Inc.
11.15.1 Sino Medical Sciences Technology Inc. Company Information
11.15.2 Sino Medical Sciences Technology Inc. Neurovascular Devices Product Offered
11.15.3 Sino Medical Sciences Technology Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Sino Medical Sciences Technology Inc. Main Business Overview
11.15.5 Sino Medical Sciences Technology Inc. Latest Developments
11.16 Beijing Taijie Weiye Technology Co., Ltd.
11.16.1 Beijing Taijie Weiye Technology Co., Ltd. Company Information
11.16.2 Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Product Offered
11.16.3 Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Beijing Taijie Weiye Technology Co., Ltd. Main Business Overview
11.16.5 Beijing Taijie Weiye Technology Co., Ltd. Latest Developments
11.17 Skynor Medical (Shanghai) Co., Ltd.
11.17.1 Skynor Medical (Shanghai) Co., Ltd. Company Information
11.17.2 Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Product Offered
11.17.3 Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Skynor Medical (Shanghai) Co., Ltd. Main Business Overview
11.17.5 Skynor Medical (Shanghai) Co., Ltd. Latest Developments
11.18 Rapid Medical Ltd.
11.18.1 Rapid Medical Ltd. Company Information
11.18.2 Rapid Medical Ltd. Neurovascular Devices Product Offered
11.18.3 Rapid Medical Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Rapid Medical Ltd. Main Business Overview
11.18.5 Rapid Medical Ltd. Latest Developments
11.19 Hunan Ruikangtong Technology Development Co., Ltd.
11.19.1 Hunan Ruikangtong Technology Development Co., Ltd. Company Information
11.19.2 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Product Offered
11.19.3 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Hunan Ruikangtong Technology Development Co., Ltd. Main Business Overview
11.19.5 Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
11.20 Suzhou Zenith Vascular Co., Ltd.
11.20.1 Suzhou Zenith Vascular Co., Ltd. Company Information
11.20.2 Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Product Offered
11.20.3 Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Suzhou Zenith Vascular Co., Ltd. Main Business Overview
11.20.5 Suzhou Zenith Vascular Co., Ltd. Latest Developments
11.21 KANEKA CORPORATION
11.21.1 KANEKA CORPORATION Company Information
11.21.2 KANEKA CORPORATION Neurovascular Devices Product Offered
11.21.3 KANEKA CORPORATION Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 KANEKA CORPORATION Main Business Overview
11.21.5 KANEKA CORPORATION Latest Developments
11.22 Route 92 Medical, Inc.
11.22.1 Route 92 Medical, Inc. Company Information
11.22.2 Route 92 Medical, Inc. Neurovascular Devices Product Offered
11.22.3 Route 92 Medical, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Route 92 Medical, Inc. Main Business Overview
11.22.5 Route 92 Medical, Inc. Latest Developments
11.23 Q'Apel Medical, Inc.
11.23.1 Q'Apel Medical, Inc. Company Information
11.23.2 Q'Apel Medical, Inc. Neurovascular Devices Product Offered
11.23.3 Q'Apel Medical, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Q'Apel Medical, Inc. Main Business Overview
11.23.5 Q'Apel Medical, Inc. Latest Developments
11.24 Vesalio, Inc.
11.24.1 Vesalio, Inc. Company Information
11.24.2 Vesalio, Inc. Neurovascular Devices Product Offered
11.24.3 Vesalio, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Vesalio, Inc. Main Business Overview
11.24.5 Vesalio, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Devices Market Size (2021-2032)
2.1.2 Neurovascular Devices Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Neurovascular Devices by Country/Region (2021, 2025 & 2032)
2.2 Neurovascular Devices Segment by Type
2.2.1 Catheter-Based Devices
2.2.2 Stent and Mesh-Based Devices
2.2.3 Coil-Based Devices
2.2.4 Others
2.2.5 Neurovascular Devices Market Size by Type
2.2.5.1 Neurovascular Devices Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Neurovascular Devices Market Size Market Share by Type (2021-2026)
2.3 Neurovascular Devices Segment by Implantation Status
2.3.1 Permanent Implantable and Embolic Products
2.3.2 Temporary Intravascular Devices
2.3.3 External Equipment
2.3.4 Neurovascular Devices Market Size by Implantation Status
2.3.4.1 Neurovascular Devices Market Size CAGR by Implantation Status (2021 VS 2025 VS 2032)
2.3.4.2 Global Neurovascular Devices Market Size Market Share by Implantation Status (2021-2026)
2.4 Neurovascular Devices Segment by Access Route
2.4.1 Femoral Artery Access
2.4.2 Radial Artery Access
2.4.3 Others
2.4.4 Neurovascular Devices Market Size by Access Route
2.4.4.1 Neurovascular Devices Market Size CAGR by Access Route (2021 VS 2025 VS 2032)
2.4.4.2 Global Neurovascular Devices Market Size Market Share by Access Route (2021-2026)
2.5 Neurovascular Devices Segment by Application
2.5.1 Acute Ischemic Stroke
2.5.2 Intracranial Aneurysm
2.5.3 Others
2.5.4 Neurovascular Devices Market Size by Application
2.5.4.1 Neurovascular Devices Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Neurovascular Devices Market Size Market Share by Application (2021-2026)
3 NEUROVASCULAR DEVICES MARKET SIZE BY PLAYER
3.1 Neurovascular Devices Market Size Market Share by Player
3.1.1 Global Neurovascular Devices Revenue by Player (2021-2026)
3.1.2 Global Neurovascular Devices Revenue Market Share by Player (2021-2026)
3.2 Global Neurovascular Devices Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROVASCULAR DEVICES BY REGION
4.1 Neurovascular Devices Market Size by Region (2021-2026)
4.2 Global Neurovascular Devices Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurovascular Devices Market Size Growth (2021-2026)
4.4 APAC Neurovascular Devices Market Size Growth (2021-2026)
4.5 Europe Neurovascular Devices Market Size Growth (2021-2026)
4.6 Middle East & Africa Neurovascular Devices Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Neurovascular Devices Market Size by Country (2021-2026)
5.2 Americas Neurovascular Devices Market Size by Type (2021-2026)
5.3 Americas Neurovascular Devices Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Devices Market Size by Region (2021-2026)
6.2 APAC Neurovascular Devices Market Size by Type (2021-2026)
6.3 APAC Neurovascular Devices Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurovascular Devices Market Size by Country (2021-2026)
7.2 Europe Neurovascular Devices Market Size by Type (2021-2026)
7.3 Europe Neurovascular Devices Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Devices by Region (2021-2026)
8.2 Middle East & Africa Neurovascular Devices Market Size by Type (2021-2026)
8.3 Middle East & Africa Neurovascular Devices Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROVASCULAR DEVICES MARKET FORECAST
10.1 Global Neurovascular Devices Forecast by Region (2027-2032)
10.1.1 Global Neurovascular Devices Forecast by Region (2027-2032)
10.1.2 Americas Neurovascular Devices Forecast
10.1.3 APAC Neurovascular Devices Forecast
10.1.4 Europe Neurovascular Devices Forecast
10.1.5 Middle East & Africa Neurovascular Devices Forecast
10.2 Americas Neurovascular Devices Forecast by Country (2027-2032)
10.2.1 United States Market Neurovascular Devices Forecast
10.2.2 Canada Market Neurovascular Devices Forecast
10.2.3 Mexico Market Neurovascular Devices Forecast
10.2.4 Brazil Market Neurovascular Devices Forecast
10.3 APAC Neurovascular Devices Forecast by Region (2027-2032)
10.3.1 China Neurovascular Devices Market Forecast
10.3.2 Japan Market Neurovascular Devices Forecast
10.3.3 Korea Market Neurovascular Devices Forecast
10.3.4 Southeast Asia Market Neurovascular Devices Forecast
10.3.5 India Market Neurovascular Devices Forecast
10.3.6 Australia Market Neurovascular Devices Forecast
10.4 Europe Neurovascular Devices Forecast by Country (2027-2032)
10.4.1 Germany Market Neurovascular Devices Forecast
10.4.2 France Market Neurovascular Devices Forecast
10.4.3 UK Market Neurovascular Devices Forecast
10.4.4 Italy Market Neurovascular Devices Forecast
10.4.5 Russia Market Neurovascular Devices Forecast
10.5 Middle East & Africa Neurovascular Devices Forecast by Region (2027-2032)
10.5.1 Egypt Market Neurovascular Devices Forecast
10.5.2 South Africa Market Neurovascular Devices Forecast
10.5.3 Israel Market Neurovascular Devices Forecast
10.5.4 Turkey Market Neurovascular Devices Forecast
10.6 Global Neurovascular Devices Forecast by Type (2027-2032)
10.7 Global Neurovascular Devices Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Neurovascular Devices Forecast
11 KEY PLAYERS ANALYSIS
11.1 Medtronic plc
11.1.1 Medtronic plc Company Information
11.1.2 Medtronic plc Neurovascular Devices Product Offered
11.1.3 Medtronic plc Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Medtronic plc Main Business Overview
11.1.5 Medtronic plc Latest Developments
11.2 Stryker Corporation
11.2.1 Stryker Corporation Company Information
11.2.2 Stryker Corporation Neurovascular Devices Product Offered
11.2.3 Stryker Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Stryker Corporation Main Business Overview
11.2.5 Stryker Corporation Latest Developments
11.3 Terumo Corporation
11.3.1 Terumo Corporation Company Information
11.3.2 Terumo Corporation Neurovascular Devices Product Offered
11.3.3 Terumo Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Terumo Corporation Main Business Overview
11.3.5 Terumo Corporation Latest Developments
11.4 Penumbra, Inc.
11.4.1 Penumbra, Inc. Company Information
11.4.2 Penumbra, Inc. Neurovascular Devices Product Offered
11.4.3 Penumbra, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Penumbra, Inc. Main Business Overview
11.4.5 Penumbra, Inc. Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Neurovascular Devices Product Offered
11.5.3 Johnson & Johnson Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 BALT SAS
11.6.1 BALT SAS Company Information
11.6.2 BALT SAS Neurovascular Devices Product Offered
11.6.3 BALT SAS Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 BALT SAS Main Business Overview
11.6.5 BALT SAS Latest Developments
11.7 Wallaby Medical Holding, Inc.
11.7.1 Wallaby Medical Holding, Inc. Company Information
11.7.2 Wallaby Medical Holding, Inc. Neurovascular Devices Product Offered
11.7.3 Wallaby Medical Holding, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Wallaby Medical Holding, Inc. Main Business Overview
11.7.5 Wallaby Medical Holding, Inc. Latest Developments
11.8 MicroPort NeuroScientific Corporation
11.8.1 MicroPort NeuroScientific Corporation Company Information
11.8.2 MicroPort NeuroScientific Corporation Neurovascular Devices Product Offered
11.8.3 MicroPort NeuroScientific Corporation Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 MicroPort NeuroScientific Corporation Main Business Overview
11.8.5 MicroPort NeuroScientific Corporation Latest Developments
11.9 Zylox-Tonbridge Medical Technology Co., Ltd.
11.9.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
11.9.2 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Product Offered
11.9.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
11.9.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
11.10 ACANDIS GmbH
11.10.1 ACANDIS GmbH Company Information
11.10.2 ACANDIS GmbH Neurovascular Devices Product Offered
11.10.3 ACANDIS GmbH Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 ACANDIS GmbH Main Business Overview
11.10.5 ACANDIS GmbH Latest Developments
11.11 Peijia Medical Limited
11.11.1 Peijia Medical Limited Company Information
11.11.2 Peijia Medical Limited Neurovascular Devices Product Offered
11.11.3 Peijia Medical Limited Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Peijia Medical Limited Main Business Overview
11.11.5 Peijia Medical Limited Latest Developments
11.12 ASAHI INTECC CO., LTD.
11.12.1 ASAHI INTECC CO., LTD. Company Information
11.12.2 ASAHI INTECC CO., LTD. Neurovascular Devices Product Offered
11.12.3 ASAHI INTECC CO., LTD. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 ASAHI INTECC CO., LTD. Main Business Overview
11.12.5 ASAHI INTECC CO., LTD. Latest Developments
11.13 Imperative Care, Inc.
11.13.1 Imperative Care, Inc. Company Information
11.13.2 Imperative Care, Inc. Neurovascular Devices Product Offered
11.13.3 Imperative Care, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Imperative Care, Inc. Main Business Overview
11.13.5 Imperative Care, Inc. Latest Developments
11.14 Shanghai HeartCare Medical Technology Corporation Limited
11.14.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
11.14.2 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Product Offered
11.14.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
11.14.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
11.15 Sino Medical Sciences Technology Inc.
11.15.1 Sino Medical Sciences Technology Inc. Company Information
11.15.2 Sino Medical Sciences Technology Inc. Neurovascular Devices Product Offered
11.15.3 Sino Medical Sciences Technology Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Sino Medical Sciences Technology Inc. Main Business Overview
11.15.5 Sino Medical Sciences Technology Inc. Latest Developments
11.16 Beijing Taijie Weiye Technology Co., Ltd.
11.16.1 Beijing Taijie Weiye Technology Co., Ltd. Company Information
11.16.2 Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Product Offered
11.16.3 Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Beijing Taijie Weiye Technology Co., Ltd. Main Business Overview
11.16.5 Beijing Taijie Weiye Technology Co., Ltd. Latest Developments
11.17 Skynor Medical (Shanghai) Co., Ltd.
11.17.1 Skynor Medical (Shanghai) Co., Ltd. Company Information
11.17.2 Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Product Offered
11.17.3 Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Skynor Medical (Shanghai) Co., Ltd. Main Business Overview
11.17.5 Skynor Medical (Shanghai) Co., Ltd. Latest Developments
11.18 Rapid Medical Ltd.
11.18.1 Rapid Medical Ltd. Company Information
11.18.2 Rapid Medical Ltd. Neurovascular Devices Product Offered
11.18.3 Rapid Medical Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Rapid Medical Ltd. Main Business Overview
11.18.5 Rapid Medical Ltd. Latest Developments
11.19 Hunan Ruikangtong Technology Development Co., Ltd.
11.19.1 Hunan Ruikangtong Technology Development Co., Ltd. Company Information
11.19.2 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Product Offered
11.19.3 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Hunan Ruikangtong Technology Development Co., Ltd. Main Business Overview
11.19.5 Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
11.20 Suzhou Zenith Vascular Co., Ltd.
11.20.1 Suzhou Zenith Vascular Co., Ltd. Company Information
11.20.2 Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Product Offered
11.20.3 Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Suzhou Zenith Vascular Co., Ltd. Main Business Overview
11.20.5 Suzhou Zenith Vascular Co., Ltd. Latest Developments
11.21 KANEKA CORPORATION
11.21.1 KANEKA CORPORATION Company Information
11.21.2 KANEKA CORPORATION Neurovascular Devices Product Offered
11.21.3 KANEKA CORPORATION Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 KANEKA CORPORATION Main Business Overview
11.21.5 KANEKA CORPORATION Latest Developments
11.22 Route 92 Medical, Inc.
11.22.1 Route 92 Medical, Inc. Company Information
11.22.2 Route 92 Medical, Inc. Neurovascular Devices Product Offered
11.22.3 Route 92 Medical, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Route 92 Medical, Inc. Main Business Overview
11.22.5 Route 92 Medical, Inc. Latest Developments
11.23 Q'Apel Medical, Inc.
11.23.1 Q'Apel Medical, Inc. Company Information
11.23.2 Q'Apel Medical, Inc. Neurovascular Devices Product Offered
11.23.3 Q'Apel Medical, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Q'Apel Medical, Inc. Main Business Overview
11.23.5 Q'Apel Medical, Inc. Latest Developments
11.24 Vesalio, Inc.
11.24.1 Vesalio, Inc. Company Information
11.24.2 Vesalio, Inc. Neurovascular Devices Product Offered
11.24.3 Vesalio, Inc. Neurovascular Devices Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Vesalio, Inc. Main Business Overview
11.24.5 Vesalio, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurovascular Devices Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neurovascular Devices Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Catheter-Based Devices
Table 4. Major Players of Stent and Mesh-Based Devices
Table 5. Major Players of Coil-Based Devices
Table 6. Major Players of Others
Table 7. Neurovascular Devices Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Neurovascular Devices Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Permanent Implantable and Embolic Products
Table 11. Major Players of Temporary Intravascular Devices
Table 12. Major Players of External Equipment
Table 13. Neurovascular Devices Market Size CAGR by Implantation Status (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Neurovascular Devices Market Size by Implantation Status (2021-2026) & ($ millions)
Table 15. Global Neurovascular Devices Market Size Market Share by Implantation Status (2021-2026)
Table 16. Major Players of Femoral Artery Access
Table 17. Major Players of Radial Artery Access
Table 18. Major Players of Others
Table 19. Neurovascular Devices Market Size CAGR by Access Route (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Neurovascular Devices Market Size by Access Route (2021-2026) & ($ millions)
Table 21. Global Neurovascular Devices Market Size Market Share by Access Route (2021-2026)
Table 22. Neurovascular Devices Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Neurovascular Devices Market Size Market Share by Application (2021-2026)
Table 25. Global Neurovascular Devices Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Neurovascular Devices Revenue Market Share by Player (2021-2026)
Table 27. Neurovascular Devices Key Players Head office and Products Offered
Table 28. Neurovascular Devices Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Neurovascular Devices Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Neurovascular Devices Market Size Market Share by Region (2021-2026)
Table 33. Global Neurovascular Devices Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Neurovascular Devices Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Neurovascular Devices Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Neurovascular Devices Market Size Market Share by Country (2021-2026)
Table 37. Americas Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Neurovascular Devices Market Size Market Share by Type (2021-2026)
Table 39. Americas Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Neurovascular Devices Market Size Market Share by Application (2021-2026)
Table 41. APAC Neurovascular Devices Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Neurovascular Devices Market Size Market Share by Region (2021-2026)
Table 43. APAC Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Neurovascular Devices Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Neurovascular Devices Market Size Market Share by Country (2021-2026)
Table 47. Europe Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Neurovascular Devices Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Neurovascular Devices
Table 53. Key Market Challenges & Risks of Neurovascular Devices
Table 54. Key Industry Trends of Neurovascular Devices
Table 55. Global Neurovascular Devices Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Neurovascular Devices Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Neurovascular Devices Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Neurovascular Devices Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Medtronic plc Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 60. Medtronic plc Neurovascular Devices Product Offered
Table 61. Medtronic plc Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Medtronic plc Main Business
Table 63. Medtronic plc Latest Developments
Table 64. Stryker Corporation Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 65. Stryker Corporation Neurovascular Devices Product Offered
Table 66. Stryker Corporation Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Stryker Corporation Main Business
Table 68. Stryker Corporation Latest Developments
Table 69. Terumo Corporation Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 70. Terumo Corporation Neurovascular Devices Product Offered
Table 71. Terumo Corporation Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Terumo Corporation Main Business
Table 73. Terumo Corporation Latest Developments
Table 74. Penumbra, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 75. Penumbra, Inc. Neurovascular Devices Product Offered
Table 76. Penumbra, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Penumbra, Inc. Main Business
Table 78. Penumbra, Inc. Latest Developments
Table 79. Johnson & Johnson Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 80. Johnson & Johnson Neurovascular Devices Product Offered
Table 81. Johnson & Johnson Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. BALT SAS Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 85. BALT SAS Neurovascular Devices Product Offered
Table 86. BALT SAS Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. BALT SAS Main Business
Table 88. BALT SAS Latest Developments
Table 89. Wallaby Medical Holding, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 90. Wallaby Medical Holding, Inc. Neurovascular Devices Product Offered
Table 91. Wallaby Medical Holding, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Wallaby Medical Holding, Inc. Main Business
Table 93. Wallaby Medical Holding, Inc. Latest Developments
Table 94. MicroPort NeuroScientific Corporation Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 95. MicroPort NeuroScientific Corporation Neurovascular Devices Product Offered
Table 96. MicroPort NeuroScientific Corporation Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. MicroPort NeuroScientific Corporation Main Business
Table 98. MicroPort NeuroScientific Corporation Latest Developments
Table 99. Zylox-Tonbridge Medical Technology Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 100. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Product Offered
Table 101. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Zylox-Tonbridge Medical Technology Co., Ltd. Main Business
Table 103. Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
Table 104. ACANDIS GmbH Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 105. ACANDIS GmbH Neurovascular Devices Product Offered
Table 106. ACANDIS GmbH Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. ACANDIS GmbH Main Business
Table 108. ACANDIS GmbH Latest Developments
Table 109. Peijia Medical Limited Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 110. Peijia Medical Limited Neurovascular Devices Product Offered
Table 111. Peijia Medical Limited Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Peijia Medical Limited Main Business
Table 113. Peijia Medical Limited Latest Developments
Table 114. ASAHI INTECC CO., LTD. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 115. ASAHI INTECC CO., LTD. Neurovascular Devices Product Offered
Table 116. ASAHI INTECC CO., LTD. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. ASAHI INTECC CO., LTD. Main Business
Table 118. ASAHI INTECC CO., LTD. Latest Developments
Table 119. Imperative Care, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 120. Imperative Care, Inc. Neurovascular Devices Product Offered
Table 121. Imperative Care, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Imperative Care, Inc. Main Business
Table 123. Imperative Care, Inc. Latest Developments
Table 124. Shanghai HeartCare Medical Technology Corporation Limited Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 125. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Product Offered
Table 126. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Shanghai HeartCare Medical Technology Corporation Limited Main Business
Table 128. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
Table 129. Sino Medical Sciences Technology Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 130. Sino Medical Sciences Technology Inc. Neurovascular Devices Product Offered
Table 131. Sino Medical Sciences Technology Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Sino Medical Sciences Technology Inc. Main Business
Table 133. Sino Medical Sciences Technology Inc. Latest Developments
Table 134. Beijing Taijie Weiye Technology Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 135. Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Product Offered
Table 136. Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Beijing Taijie Weiye Technology Co., Ltd. Main Business
Table 138. Beijing Taijie Weiye Technology Co., Ltd. Latest Developments
Table 139. Skynor Medical (Shanghai) Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 140. Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Product Offered
Table 141. Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Skynor Medical (Shanghai) Co., Ltd. Main Business
Table 143. Skynor Medical (Shanghai) Co., Ltd. Latest Developments
Table 144. Rapid Medical Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 145. Rapid Medical Ltd. Neurovascular Devices Product Offered
Table 146. Rapid Medical Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Rapid Medical Ltd. Main Business
Table 148. Rapid Medical Ltd. Latest Developments
Table 149. Hunan Ruikangtong Technology Development Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 150. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Product Offered
Table 151. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Hunan Ruikangtong Technology Development Co., Ltd. Main Business
Table 153. Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
Table 154. Suzhou Zenith Vascular Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 155. Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Product Offered
Table 156. Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Suzhou Zenith Vascular Co., Ltd. Main Business
Table 158. Suzhou Zenith Vascular Co., Ltd. Latest Developments
Table 159. KANEKA CORPORATION Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 160. KANEKA CORPORATION Neurovascular Devices Product Offered
Table 161. KANEKA CORPORATION Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. KANEKA CORPORATION Main Business
Table 163. KANEKA CORPORATION Latest Developments
Table 164. Route 92 Medical, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 165. Route 92 Medical, Inc. Neurovascular Devices Product Offered
Table 166. Route 92 Medical, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 167. Route 92 Medical, Inc. Main Business
Table 168. Route 92 Medical, Inc. Latest Developments
Table 169. Q'Apel Medical, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 170. Q'Apel Medical, Inc. Neurovascular Devices Product Offered
Table 171. Q'Apel Medical, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 172. Q'Apel Medical, Inc. Main Business
Table 173. Q'Apel Medical, Inc. Latest Developments
Table 174. Vesalio, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 175. Vesalio, Inc. Neurovascular Devices Product Offered
Table 176. Vesalio, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 177. Vesalio, Inc. Main Business
Table 178. Vesalio, Inc. Latest Developments
Table 1. Neurovascular Devices Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Neurovascular Devices Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Catheter-Based Devices
Table 4. Major Players of Stent and Mesh-Based Devices
Table 5. Major Players of Coil-Based Devices
Table 6. Major Players of Others
Table 7. Neurovascular Devices Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Neurovascular Devices Market Size Market Share by Type (2021-2026)
Table 10. Major Players of Permanent Implantable and Embolic Products
Table 11. Major Players of Temporary Intravascular Devices
Table 12. Major Players of External Equipment
Table 13. Neurovascular Devices Market Size CAGR by Implantation Status (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Neurovascular Devices Market Size by Implantation Status (2021-2026) & ($ millions)
Table 15. Global Neurovascular Devices Market Size Market Share by Implantation Status (2021-2026)
Table 16. Major Players of Femoral Artery Access
Table 17. Major Players of Radial Artery Access
Table 18. Major Players of Others
Table 19. Neurovascular Devices Market Size CAGR by Access Route (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Neurovascular Devices Market Size by Access Route (2021-2026) & ($ millions)
Table 21. Global Neurovascular Devices Market Size Market Share by Access Route (2021-2026)
Table 22. Neurovascular Devices Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 23. Global Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 24. Global Neurovascular Devices Market Size Market Share by Application (2021-2026)
Table 25. Global Neurovascular Devices Revenue by Player (2021-2026) & ($ millions)
Table 26. Global Neurovascular Devices Revenue Market Share by Player (2021-2026)
Table 27. Neurovascular Devices Key Players Head office and Products Offered
Table 28. Neurovascular Devices Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 29. New Products and Potential Entrants
Table 30. Mergers & Acquisitions, Expansion
Table 31. Global Neurovascular Devices Market Size by Region (2021-2026) & ($ millions)
Table 32. Global Neurovascular Devices Market Size Market Share by Region (2021-2026)
Table 33. Global Neurovascular Devices Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Neurovascular Devices Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Neurovascular Devices Market Size by Country (2021-2026) & ($ millions)
Table 36. Americas Neurovascular Devices Market Size Market Share by Country (2021-2026)
Table 37. Americas Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 38. Americas Neurovascular Devices Market Size Market Share by Type (2021-2026)
Table 39. Americas Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 40. Americas Neurovascular Devices Market Size Market Share by Application (2021-2026)
Table 41. APAC Neurovascular Devices Market Size by Region (2021-2026) & ($ millions)
Table 42. APAC Neurovascular Devices Market Size Market Share by Region (2021-2026)
Table 43. APAC Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 44. APAC Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 45. Europe Neurovascular Devices Market Size by Country (2021-2026) & ($ millions)
Table 46. Europe Neurovascular Devices Market Size Market Share by Country (2021-2026)
Table 47. Europe Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 48. Europe Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 49. Middle East & Africa Neurovascular Devices Market Size by Region (2021-2026) & ($ millions)
Table 50. Middle East & Africa Neurovascular Devices Market Size by Type (2021-2026) & ($ millions)
Table 51. Middle East & Africa Neurovascular Devices Market Size by Application (2021-2026) & ($ millions)
Table 52. Key Market Drivers & Growth Opportunities of Neurovascular Devices
Table 53. Key Market Challenges & Risks of Neurovascular Devices
Table 54. Key Industry Trends of Neurovascular Devices
Table 55. Global Neurovascular Devices Market Size Forecast by Region (2027-2032) & ($ millions)
Table 56. Global Neurovascular Devices Market Size Market Share Forecast by Region (2027-2032)
Table 57. Global Neurovascular Devices Market Size Forecast by Type (2027-2032) & ($ millions)
Table 58. Global Neurovascular Devices Market Size Forecast by Application (2027-2032) & ($ millions)
Table 59. Medtronic plc Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 60. Medtronic plc Neurovascular Devices Product Offered
Table 61. Medtronic plc Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 62. Medtronic plc Main Business
Table 63. Medtronic plc Latest Developments
Table 64. Stryker Corporation Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 65. Stryker Corporation Neurovascular Devices Product Offered
Table 66. Stryker Corporation Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 67. Stryker Corporation Main Business
Table 68. Stryker Corporation Latest Developments
Table 69. Terumo Corporation Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 70. Terumo Corporation Neurovascular Devices Product Offered
Table 71. Terumo Corporation Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 72. Terumo Corporation Main Business
Table 73. Terumo Corporation Latest Developments
Table 74. Penumbra, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 75. Penumbra, Inc. Neurovascular Devices Product Offered
Table 76. Penumbra, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 77. Penumbra, Inc. Main Business
Table 78. Penumbra, Inc. Latest Developments
Table 79. Johnson & Johnson Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 80. Johnson & Johnson Neurovascular Devices Product Offered
Table 81. Johnson & Johnson Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. BALT SAS Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 85. BALT SAS Neurovascular Devices Product Offered
Table 86. BALT SAS Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 87. BALT SAS Main Business
Table 88. BALT SAS Latest Developments
Table 89. Wallaby Medical Holding, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 90. Wallaby Medical Holding, Inc. Neurovascular Devices Product Offered
Table 91. Wallaby Medical Holding, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 92. Wallaby Medical Holding, Inc. Main Business
Table 93. Wallaby Medical Holding, Inc. Latest Developments
Table 94. MicroPort NeuroScientific Corporation Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 95. MicroPort NeuroScientific Corporation Neurovascular Devices Product Offered
Table 96. MicroPort NeuroScientific Corporation Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 97. MicroPort NeuroScientific Corporation Main Business
Table 98. MicroPort NeuroScientific Corporation Latest Developments
Table 99. Zylox-Tonbridge Medical Technology Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 100. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Product Offered
Table 101. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 102. Zylox-Tonbridge Medical Technology Co., Ltd. Main Business
Table 103. Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
Table 104. ACANDIS GmbH Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 105. ACANDIS GmbH Neurovascular Devices Product Offered
Table 106. ACANDIS GmbH Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 107. ACANDIS GmbH Main Business
Table 108. ACANDIS GmbH Latest Developments
Table 109. Peijia Medical Limited Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 110. Peijia Medical Limited Neurovascular Devices Product Offered
Table 111. Peijia Medical Limited Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 112. Peijia Medical Limited Main Business
Table 113. Peijia Medical Limited Latest Developments
Table 114. ASAHI INTECC CO., LTD. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 115. ASAHI INTECC CO., LTD. Neurovascular Devices Product Offered
Table 116. ASAHI INTECC CO., LTD. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 117. ASAHI INTECC CO., LTD. Main Business
Table 118. ASAHI INTECC CO., LTD. Latest Developments
Table 119. Imperative Care, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 120. Imperative Care, Inc. Neurovascular Devices Product Offered
Table 121. Imperative Care, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 122. Imperative Care, Inc. Main Business
Table 123. Imperative Care, Inc. Latest Developments
Table 124. Shanghai HeartCare Medical Technology Corporation Limited Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 125. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Product Offered
Table 126. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 127. Shanghai HeartCare Medical Technology Corporation Limited Main Business
Table 128. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
Table 129. Sino Medical Sciences Technology Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 130. Sino Medical Sciences Technology Inc. Neurovascular Devices Product Offered
Table 131. Sino Medical Sciences Technology Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 132. Sino Medical Sciences Technology Inc. Main Business
Table 133. Sino Medical Sciences Technology Inc. Latest Developments
Table 134. Beijing Taijie Weiye Technology Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 135. Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Product Offered
Table 136. Beijing Taijie Weiye Technology Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 137. Beijing Taijie Weiye Technology Co., Ltd. Main Business
Table 138. Beijing Taijie Weiye Technology Co., Ltd. Latest Developments
Table 139. Skynor Medical (Shanghai) Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 140. Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Product Offered
Table 141. Skynor Medical (Shanghai) Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 142. Skynor Medical (Shanghai) Co., Ltd. Main Business
Table 143. Skynor Medical (Shanghai) Co., Ltd. Latest Developments
Table 144. Rapid Medical Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 145. Rapid Medical Ltd. Neurovascular Devices Product Offered
Table 146. Rapid Medical Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 147. Rapid Medical Ltd. Main Business
Table 148. Rapid Medical Ltd. Latest Developments
Table 149. Hunan Ruikangtong Technology Development Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 150. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Product Offered
Table 151. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 152. Hunan Ruikangtong Technology Development Co., Ltd. Main Business
Table 153. Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
Table 154. Suzhou Zenith Vascular Co., Ltd. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 155. Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Product Offered
Table 156. Suzhou Zenith Vascular Co., Ltd. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 157. Suzhou Zenith Vascular Co., Ltd. Main Business
Table 158. Suzhou Zenith Vascular Co., Ltd. Latest Developments
Table 159. KANEKA CORPORATION Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 160. KANEKA CORPORATION Neurovascular Devices Product Offered
Table 161. KANEKA CORPORATION Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 162. KANEKA CORPORATION Main Business
Table 163. KANEKA CORPORATION Latest Developments
Table 164. Route 92 Medical, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 165. Route 92 Medical, Inc. Neurovascular Devices Product Offered
Table 166. Route 92 Medical, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 167. Route 92 Medical, Inc. Main Business
Table 168. Route 92 Medical, Inc. Latest Developments
Table 169. Q'Apel Medical, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 170. Q'Apel Medical, Inc. Neurovascular Devices Product Offered
Table 171. Q'Apel Medical, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 172. Q'Apel Medical, Inc. Main Business
Table 173. Q'Apel Medical, Inc. Latest Developments
Table 174. Vesalio, Inc. Details, Company Type, Neurovascular Devices Area Served and Its Competitors
Table 175. Vesalio, Inc. Neurovascular Devices Product Offered
Table 176. Vesalio, Inc. Neurovascular Devices Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 177. Vesalio, Inc. Main Business
Table 178. Vesalio, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Neurovascular Devices Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurovascular Devices Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neurovascular Devices Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neurovascular Devices Sales Market Share by Country/Region (2025)
Figure 8. Neurovascular Devices Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neurovascular Devices Market Size Market Share by Type in 2025
Figure 10. Global Neurovascular Devices Market Size Market Share by Implantation Status in 2025
Figure 11. Global Neurovascular Devices Market Size Market Share by Access Route in 2025
Figure 12. Neurovascular Devices in Acute Ischemic Stroke
Figure 13. Global Neurovascular Devices Market: Acute Ischemic Stroke (2021-2026) & ($ millions)
Figure 14. Neurovascular Devices in Intracranial Aneurysm
Figure 15. Global Neurovascular Devices Market: Intracranial Aneurysm (2021-2026) & ($ millions)
Figure 16. Neurovascular Devices in Others
Figure 17. Global Neurovascular Devices Market: Others (2021-2026) & ($ millions)
Figure 18. Global Neurovascular Devices Market Size Market Share by Application in 2025
Figure 19. Global Neurovascular Devices Revenue Market Share by Player in 2025
Figure 20. Global Neurovascular Devices Market Size Market Share by Region (2021-2026)
Figure 21. Americas Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 22. APAC Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 23. Europe Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 25. Americas Neurovascular Devices Value Market Share by Country in 2025
Figure 26. United States Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Neurovascular Devices Market Size Market Share by Region in 2025
Figure 31. APAC Neurovascular Devices Market Size Market Share by Type (2021-2026)
Figure 32. APAC Neurovascular Devices Market Size Market Share by Application (2021-2026)
Figure 33. China Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 37. India Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Neurovascular Devices Market Size Market Share by Country in 2025
Figure 40. Europe Neurovascular Devices Market Size Market Share by Type (2021-2026)
Figure 41. Europe Neurovascular Devices Market Size Market Share by Application (2021-2026)
Figure 42. Germany Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 43. France Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Neurovascular Devices Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Neurovascular Devices Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Neurovascular Devices Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 56. APAC Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 57. Europe Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 59. United States Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 60. Canada Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 61. Mexico Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 62. Brazil Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 63. China Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 64. Japan Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 65. Korea Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 67. India Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 68. Australia Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 69. Germany Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 70. France Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 71. UK Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 72. Italy Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 73. Russia Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 74. Egypt Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 75. South Africa Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 76. Israel Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 77. Turkey Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 78. Global Neurovascular Devices Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Neurovascular Devices Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 1. Neurovascular Devices Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurovascular Devices Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Neurovascular Devices Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Neurovascular Devices Sales Market Share by Country/Region (2025)
Figure 8. Neurovascular Devices Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Neurovascular Devices Market Size Market Share by Type in 2025
Figure 10. Global Neurovascular Devices Market Size Market Share by Implantation Status in 2025
Figure 11. Global Neurovascular Devices Market Size Market Share by Access Route in 2025
Figure 12. Neurovascular Devices in Acute Ischemic Stroke
Figure 13. Global Neurovascular Devices Market: Acute Ischemic Stroke (2021-2026) & ($ millions)
Figure 14. Neurovascular Devices in Intracranial Aneurysm
Figure 15. Global Neurovascular Devices Market: Intracranial Aneurysm (2021-2026) & ($ millions)
Figure 16. Neurovascular Devices in Others
Figure 17. Global Neurovascular Devices Market: Others (2021-2026) & ($ millions)
Figure 18. Global Neurovascular Devices Market Size Market Share by Application in 2025
Figure 19. Global Neurovascular Devices Revenue Market Share by Player in 2025
Figure 20. Global Neurovascular Devices Market Size Market Share by Region (2021-2026)
Figure 21. Americas Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 22. APAC Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 23. Europe Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Neurovascular Devices Market Size 2021-2026 ($ millions)
Figure 25. Americas Neurovascular Devices Value Market Share by Country in 2025
Figure 26. United States Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Neurovascular Devices Market Size Market Share by Region in 2025
Figure 31. APAC Neurovascular Devices Market Size Market Share by Type (2021-2026)
Figure 32. APAC Neurovascular Devices Market Size Market Share by Application (2021-2026)
Figure 33. China Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 37. India Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Neurovascular Devices Market Size Market Share by Country in 2025
Figure 40. Europe Neurovascular Devices Market Size Market Share by Type (2021-2026)
Figure 41. Europe Neurovascular Devices Market Size Market Share by Application (2021-2026)
Figure 42. Germany Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 43. France Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Neurovascular Devices Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Neurovascular Devices Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Neurovascular Devices Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Neurovascular Devices Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 56. APAC Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 57. Europe Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 59. United States Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 60. Canada Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 61. Mexico Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 62. Brazil Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 63. China Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 64. Japan Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 65. Korea Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 67. India Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 68. Australia Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 69. Germany Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 70. France Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 71. UK Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 72. Italy Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 73. Russia Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 74. Egypt Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 75. South Africa Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 76. Israel Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 77. Turkey Neurovascular Devices Market Size 2027-2032 ($ millions)
Figure 78. Global Neurovascular Devices Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Neurovascular Devices Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Neurovascular Devices Market Size 2027-2032 ($ millions)
